Viveo plans to wait out volatility for follow-on

Viveo plans to wait out volatility for follow-on

Corporate & Sovereign Strategy Equity IPO M&A Brazil Capital Markets Interviews Healthcare

Brazilian medical supplies company Viveo would consider a follow-on offering in the next 12 to 24 months, but current market conditions would be too volatile, CEO Leonardo Byrro told LatinFinance. "The way the markets are at the moment, it would be difficult. I would not do it now because we do not need it," Byrro said. Viveo raised BRL1.88 billion ($338 million) in an initial public offering (IPO) in August, keeping BRL580 million itself from the sale of new shares. Singapore's sovereign wealth

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial